Company: INKT
Filing Date: 2025-12-08
Form Type: 8-K
Source: 0001193125-25-311229
Chunk: 1

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-12-08
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibit

The following exhibits are furnished herewith: Press Release dated November 14, 2025

99.2Transcript of Conference Call dated November 14, 2025

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date:      December 8, 2025      By:      /s/ Christine M. Klaskin         
 ─────────────────────────────────────────────────────────────────────────────
                                            Christine M. Klaskin, Treasurer